Endocrinopathies such as hypothyroidism and adrenal insufficiency sometimes occur in cancer patients who receive anti-PD-L1 ICIs [44], but we did not find these AEs after retrospectively reviewing the electronic medical records. Here, CD274 is linked to cancer.